On this page Agenda Applications for consideration at this meeting 1700 Totally thoracoscopic exclusion of the left atrial appendage for patients with non-valvular atrial fibrillation 1701 Deep brain stimulation of the thalamus for the treatment of severe refractory epilepsy 1702 Abdominal MRI for rare genetic conditions associated with increased risk of renal tumours 1703 Detection of measurable residual disease in patients with acute lymphoblastic leukaemia 1705 Structured prenatal risk assessment for preterm preeclampsia 1706 Angiogenic and anti-angiogenic markers for identification and management of preeclampsia 1707 Detection of measurable residual disease in patients with acute lymphoblastic leukaemia 1708 Hepatitis Delta Virus (HDV) RNA PCR testing to determine eligibility for PBS-subsidised bulevirtide (HEPCLUDEX) for treatment of HDV 1711 Review of MBS items for subacromial decompression Related information Committee: PICO Advisory Subcommittee (PASC)